UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form

FORM 10-Q

 (Mark One)
xQUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2009

oTRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
March 31, 2023

TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT

For the transition period from __________________ to _________

Commission File Number: 333-118155
MDWERKS, INC.
_____________

MDwerks, Inc.

(Exact name of registrantsmall business issuer as specified in its charter)

Commission File No. 000-56299

Delaware33-1095411

(State or other jurisdiction

of

incorporation or organization)

(I.R.S. Employer

Identification No.)

Windolph Center,

411 Walnut Street, Suite I

1020 N.W. 6th Street
Deerfield Beach, 20125

Green Cove, FL 33442

32043

(Address of principal executive offices)Principal Executive Offices)

(252) 501-0019

(Zip Code)

(954) 389-8300
(Registrant'sIssuer’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Checknumber)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
N/AN/AN/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx No o


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every interactive data fileInteractive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yeso No o


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company.

Large accelerated filer o
Accelerated filer o
Non-accelerated filer o
Smaller reporting company x

See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso Nox

State

As of June 8, 2023, the number ofCompany has 124,734,838 shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 17,990,208 shares at November 23, 2009



stock issued and outstanding.

 

MDWERKS, INC.
FORM 10-Q
FOR THE PERIOD ENDED SEPTEMBER 30, 2009
INDEX

 Page

Table of Contents

PART I - I—FINANCIAL INFORMATION
Item 1 - Consolidated Financial Statements
Consolidated Balance Sheets At September 30, 2009 (Unaudited) and December 31, 20083
Consolidated Statements of Operations (Unaudited) For the Three and Nine Months Ended September 30, 2009 and 20084
Item 1.ConsolidatedFinancial Statements of Cash Flows (Unaudited) For the Nine Months Ended September 30, 2009 and 200854
Item 2.Notes to Unaudited Consolidated Financial Statements6-19
Item 2 - Management'sManagement’s Discussion and Analysis of Financial Condition and Results of Operations20-2511
Item 3.Item 3 - Quantitative and Qualitative Disclosures About Market Risk2616
Item 4.Item 4 - Controls and Procedures2616
PART II - II—OTHER INFORMATION17
Item 1.Item 1 - Legal Proceedings2717
Item 1A.Risk Factors17
Item 2 - 2.Unregistered Sales of Equity Securities and Use of Proceeds2717
Item 3.Item 3 - Defaults Upon Senior Securities2717
Item 4.Item 4 - Submission of Matters to a Vote of Security HoldersMine Safety Disclosure2717
Item 5.Item 5 - Other Information2717
Item 6.Item 6 - Exhibits2717
SIGNATURES18
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32.1

2

Forward-Looking Statements

Various statements contained in this report constitute “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are based on current expectations and are indicated by words or phrases such as “believe,” “expect,” “may,” “will,” “should,” “seek,” “plan,” “intend” or “anticipate” or the negative thereof or comparable terminology, or by discussion of strategy. Forward-looking statements represent as of the date of this report our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. Such forward-looking statements are based largely on our current expectations and are inherently subject to risks and uncertainties. Our actual results could differ materially from those that are anticipated or projected as a result of certain risks and uncertainties, including, but not limited to, a number of factors, such as: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles and the other risks and uncertainties that are set forth in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the Securities and Exchange Commission (“SEC”) pursuant to the SEC’s rules, we have no duty to update these statements, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, we cannot assure you that the forward-looking information contained in this report will in fact transpire.

As used in this Quarterly Report on Form 10-Q, unless the context requires or is otherwise indicated, the terms “we,” “us,” “our,” the “Registrant,” the “Company,” “our company” and similar expressions means MDwerks, Inc.

3

2


Item 1. Financial Statements

MDWERKS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
  
September 30,
2009
(Unaudited)
  
December 31,
2008 (1)
 
ASSETS       
Current assets:    
 
 
Cash $1,420,171  $1,223,807 
Notes receivable  1,418,717    1,277,722 
Accounts receivable, net of allowances of $200,000 at September 30, 2009 and December 31, 2008  459,761    188,048 
Leases receivable  139,250   85,000 
Prepaid expenses and other  35,396    132,160  
Total current assets  3,473,295    2,906,737 
Long-term assets:        
Notes receivable  390,000    
Leases receivable  110,516    
Available-for-sale securities, at fair market value  170,430   61,750 
Property and equipment, net of accumulated depreciation of $185,728 at September 30, 2009 and $179,211 at December 31, 2008  25,636    48,120 
Debt issuance and offering costs, net of accumulated amortization of $842,747 at September 30, 2009 and $505,478 at December 31, 2008  708,669    631,037 
Other non current assets  42,727    
Total assets $4,921,273  $3,647,644 
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' DEFICIENCY        
Current liabilities:        
Notes payable, net $498,512  $1,290,870 
Accounts payable  79,339    161,516 
Accrued interest  600,326     119,962 
Accrued expenses  449,797    482,663 
Dividends payable  1,738,132     948,222  
Total current liabilities  3,366,106    3,003,233 
Long-term liabilities:        
Notes payable, net  4,946,860    
Total long-term liabilities  4,946,860     — 
Total liabilities  8,312,966     3,003,233 
Temporary equity:        
Mandatorily Redeemable Convertible Series B Preferred Stock, $.001 par value, 1,500 shares authorized;1,000 shares issued and outstanding at September 30, 2009 and December 31, 2008, net  7,620,835   4,052,083 
Total temporary equity  7,620,835   4,052,083 
Stockholders’ deficiency:        
Preferred stock,  Series A preferred stock, $.001 par value, 10,000,000 shares authorized;
1 share issued and outstanding at September, 30, 2009 and 2 shares issued and outstanding at December 31, 2008
      — 
Common stock, $.001 par value, 200,000,000 shares authorized;
17,990,208 shares issued and outstanding at September 30, 2009 and
14,370,208 shares issued and outstanding at December 31, 2008
  17,990    14,370 
Additional paid-in capital  47,711,048    47,240,654 
Accumulated deficit
  (57,857,196  (49,669,646
Accumulated other comprehensive loss  (884,370)  (993,050)
Total stockholders' deficiency  (11,012,528)    (3,407,672)
Total liabilities, temporary equity and stockholders' deficiency $4,921,273  $3,647,644 

 (1) Derived from audited financial statements

Condensed Balance Sheets

(unaudited) 

  March 31,  December 31, 
  2023  2022 
ASSETS        
Cash $41,228  $23,715 
         
TOTAL ASSETS $41,228  $23,715 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
         
CURRENT LIABILITIES        
Accounts payable and accrued expenses $17,175  $34,478 
Advances payable  94,873   104,204 
         
TOTAL LIABILITIES  112,048   138,682 
         
STOCKHOLDERS’ DEFICIT        
        
Preferred stock, par value $0.001; 10,000,000 shares authorized of which 8,957,500 are issued and outstanding  8,958   8,958 
Common stock, par value $0.001; 300,000,000 shares authorized of which 122,260,208 shares are issued and outstanding at 12/31/22 and 123,401,506 shares are issued and outstanding at 3/31/23  123,401   122,260 
        
Additional paid in capital  285,988   201,531 
Accumulated deficit  (489,167)  (447,716)
         
TOTAL STOCKHOLDERS’ DEFICIT $(70,820) $(114,967)
         
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $41,228  $23,715 

The accompanying notes should be read in conjunction with theare an integral part of these unaudited consolidatedcondensed financial statements


statements.

4
3



MDWERKS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

  
For the Three Months
Ended September 30,
  
For the Nine Months
Ended September 30,
 
  
2009
(Unaudited)
  
2008
(As Restated)
(Unaudited)
  
2009
(Unaudited)
  
2008
(As Restated)
(Unaudited)
 
Revenue:            
Service fees $7,840  $109,762  $90,764  $420,212 
Financing income   85,460   63,901   275,519   195,464 
Claims purchase revenue     62,987      86,684 
Total revenue    93,300     236,650     366,283     702,360  
Operating expenses:                
Compensation   211,807   833,555   1,176,156   4,144,549 
Consulting expenses   153,596   29,630   533,084   168,349 
Professional fees   232,185   162,950   583,781   492,901 
Selling, general and administrative    153,998     343,788     690,000     1,131,814  
Total operating expenses    751,586    1,369,923    2,983,021    5,937,613 
Loss from operations    (658,286)   (1,133,273)   (2,616,738)   (5,235,253)
Other income (expense):                
Interest and other income   13,050   425,901   50,423   1,084,420 
Interest expense    (392,634)   (348,138)   (1,302,573)   (1,229,015)
Total other income (expense)    (379,584)   77,763    (1,252,150)   (144,595)
Net loss  (1,037,870)  (1,055,510)  (3,868,888)  (5,379,848)
Deemed preferred stock dividend  (1,339,494)  (1,489,584)  (4,318,662)  (3,286,414)
Net loss attributable to common shareholders $(2,377,364) $(2,545,094) $(8,187,550) $(8,666,262)
NET LOSS PER COMMON SHARE - basic and diluted $(0.13) $(0.20) $(0.50) $(0.67)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - basic and diluted    17,990,208    12,940,065    16,234,457    12,940,065 

(1) Diluted loss per common share is not presented since the impactINC,

Condensed Statements of stock options and warrants would be antidilutive. 

Operations

(unaudited)

  2023  2022 
  For the three month period ended March 31, 
  2023  2022 
       
Operating expenses        
General and administrative $41,451  $5,494  
Total operating expenses  41,451   5,494 
         
Net loss from operations  (41,451)  (5,494) 
         
Other income        
Interest  -   - 
Total other income  -   - 
         
Net loss $(41,451) $(5,494) 
         
         
Net loss per share        
Basic $(0.00) $(0.00 ) 
Diluted $(0.00) $(0.00 )
         
WEIGHTED AVERAGE NUMBER OF SHARES        
Basic  122,712,732   18,010,208  
Diluted  122,712,732   18,010,208 

The accompanying notes should be read in conjunction with theare an integral part of these unaudited consolidatedcondensed financial statements


.

5
4


MDWERKS, INC. AND SUBSIDIARIES

CONSOLIDATED

CONDENSED STATEMENTS OF CASH FLOWS

  
For the Nine Months
Ended September 30
 
  
2009
  2008 
     (As Restated) 
  (Unaudited)  (Unaudited) 
Cash flows from operating activities:         
Net loss $(3,868,888 $(5,379,848)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation   22,484   30,770 
Amortization of debt discount   747,784   930,627 
Amortization of deferred offering and debt issuance costs   337,269   184,824 
Amortization of deferred compensation   —   22,168 
Bad debts     100,000 
Stock-based compensation   329,357   2,197,482 
Changes in assets and liabilities:        
Notes receivable   (530,995  (869,698)
Accounts receivable   (271,713  (774,902
Leases receivable  (164,766)   
Prepaid expenses and other   54,037   12,257 
Accounts payable   (82,177  (43,033
Accrued interest and accrued expenses   487,498   (47,498)
Deferred revenue   —    (8,472
Total adjustments   928,778   1,734,525 
Net cash used in operating activities  (2,940,110)  (3,645,323)
Cash flows from investing activities:        
Purchase of property and equipment     (18,434
Investment in certificates of deposits     (2,000,000
Net cash used in investing activities     (2,018,434
Cash flows from financing activities:        
Proceeds from additional notes payable  3,851,375    
Repayment of notes payable   (300,000)    (1,686,112
Repayment of loan payable   —   (109,559)
Proceeds from sale of Mandatorily Redeemable Series B preferred stock     8,000,000 
Placement fees and other expenses paid   (414,901  (196,870)
Net cash provided by financing activities   3,136,474   6,007,459 
Net increase in cash   196,364   343,702 
Cash - beginning of year  1,223,807   320,903 
Cash - end of period $1,420,171  $664,605 
Supplemental disclosure of cash flow information:        
Cash paid for:        
Interest $34,425  $300,285 
CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

For the three months ended March 31, 2023 and twelve months ended December 31, 2022

  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
  Preferred Stock  Common Stock  Additional Paid-in  Accumulated    
  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
                      
Balance January 1, 2022  10,000,000  $10,000   18,010,208  $18,010  $35,195  $(294,003) $(230,798)
Net loss  -   -   -   -   -   (153,713)  (153,713)
Conversion of preferred stock  (1,042,500)  (1,042)  104,250,000   104,250   (103,208)  -   - 
Contributed Capital              30,100      30,100 
Forgiveness of debt  -       -       239,444   -   239,444 
Balance December 31, 2022  8,957,500  $8,958   122,260,208  $122,260  $201,531  $(447,716) $(114,967)
                             
Balance January 1, 2023  8,957,500  $8,958   122,260,208  $122,260  $201,531  $(447,716) $(114,967)
Balance, value  8,957,500  $8,958   122,260,208  $122,260 $201,531  $(447,716) $(114,967)
Common shares sold for cash        1,141,298  $1,141  $84,457      85,598 
Net income  -   -   -   -   -   (41,451)  (41,451)
Net income (loss)  -   -   -   -   -   (41,451)  (41,451)
Balance March 31, 2023  8,957,500  $8,958   123,401,506  $123,401  $285,988  $(489,167) $(70,820)
Balance , value  8,957,500  $8,958   123,401,506  $123,401  $285,988  $(489,167) $(70,820)

The accompanying notes should be read in conjunction withare an integral part of these unaudited condensed financial statements.

6

MDWERKS, INC,

Condensed Statements of Cash Flows

(unaudited)

  2023  2022 
  For the three month period ended March 31, 
  2023  2022 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss $(41,451) $(5,494) 
         
Adjustments to reconcile net loss to net cash used in operating activities:        
Gain on forgiveness of debt  -   - 
         
Changes in operating assets and liabilities:        
Accounts payable  (17,303)   4,494 
         
         
NET CASH USED IN OPERATING ACTIVITIES  (58,754)  (1,000) 
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchase of equipment  -   - 
         
NET CASH USED IN INVESTING ACTIVITIES  -   - 
         
CASH FLOWS FROM FINANCING ACTIVITIES        
         
Repayment of advances payable  (9,331)     
Proceeds from subscription agreements  85,598   1,000 
         
NET CASH PROVIDED BY FINANCING ACTIVITIES  76,267   1,000 
         
         
NET CHANGE IN CASH  17,513   - 
         
CASH - BEGINNING OF YEAR  

23,715

   - 
         
CASH - END OF PERIOD  41,228   - 
         
Supplemental disclosures of cash flow information:        
Cash paid for interest $-  $- 
Cash paid for taxes $-  $- 
         
Supplemental disclosure of non-cash investing and financing activities        
Forgiveness of debt as capital contribution $-  $- 
Conversion of preferred stock $-  $- 

The accompanying notes are an integral part of these unaudited condensed financial statements.

7

MDWERKS, INC.

Notes to Unaudited Condensed Financial Statements

For the unaudited consolidated financial statements


5


MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009
Three Months Ended March 31, 2023

NOTE 1 ORGANIZATION AND DESCRIPTION OF THE BUSINESS

MDWerks, Inc. (the “Company”), a Delaware corporation, is focused on effecting a “reverse merger,” capital exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more unrelated businesses (a “Business Combination”) that would benefit from the Company’s public reporting status. The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. As of the date of this report, the Company has not yet commenced any operations. All activity through the date of this report relates to preserving cash, making settlements with creditors, attempting to raise capital, and continuing the Company’s public reporting.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation The financial statements present the financial position, results of operations and cash flows of the Company in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). All dollar amounts are rounded to the nearest thousand dollars.

Cash and Cash Equivalents – The Company considers all highly liquid instruments with original maturities of three months or less when acquired, to be cash equivalents. The Company had no cash equivalents at March 31, 2023.

Income Taxes – The Company complies with the accounting and reporting requirements of US GAAP in accounting for income taxes. The Company uses the asset and liability approach to financial reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in future taxable or deductible amounts and are based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred income tax assets to the amount expected to be realized.

The Company also complies with US GAAP in accounting for uncertain tax positions. A tax benefit from an uncertain position may be recognized only if it is “more likely than not” that the position is sustainable based on its technical merits. Based on its analysis, the Company has determined that it has not incurred any liability for unrecognized tax benefits as of March 31, 2023. However, the Company’s conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, on-going analyses of and changes to tax laws, regulations and interpretations thereof. The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and other expenses, respectively. No interest expense or penalties have been recognized as of March 31, 2023.

Earnings Per Share –Earnings per share is computed based on the weighted average number of common shares outstanding.

Basic income (loss) per share excludes dilution and is computed by dividing income (loss) available to common stockholders by the weighted average common shares outstanding for the year. Diluted income (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity. For the three months ended March 31, 2023, there were no options, warrants or derivative securities outstanding. Therefore, basic and diluted loss per share were the same for the three months ended March 31, 2023.

Use of Estimates and Assumptions- The preparation of financial statements in accordance with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.

8

Organization
On November 16, 2005, a wholly owned subsidiary

Fair Value of MDwerks, Inc. (f/k/a Western Exploration, Inc.Financial Instruments - The Company measures its financial and non-financial assets and liabilities, as well as makes related disclosures, in accordance with the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) No. 820, Fair Value Measurement (“ASC 820”), which provides guidance with respect to valuation techniques to be utilized in the determination of fair value of assets and liabilities. Approaches include, (i) the market approach (comparable market prices), (ii) the income approach (present value of future income or cash flow), and hereinafter referred(iii) the cost approach (cost to replace the service capacity of an asset or replacement cost). ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

Level 1: Observable inputs such as the ‘‘Company’’) was merged withquoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and into MDwerks Global Holdings, Inc., a Florida corporation (‘‘MDwerks’’), with MDwerks surviving. quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one more significant inputs or significant value drivers are unobservable.

The Company acquired all of the outstanding capital stock of MDwerks in exchange for issuing 9,246,339 sharescarrying values of the Company’s commonaccounts payable and accrued liabilities, advances payable, and convertible notes payable, approximate their fair value due to their short-term nature.

Convertible notes payable - The Company accounts for convertible notes payable in accordance with ASC No. 815, Derivatives and Hedging, since the conversion feature is not indexed to the Company’s stock parand cannot be classified in equity. The Company allocates the proceeds received from convertible notes payable between the liability component and conversion feature component. The conversion feature that is considered embedded derivative liabilities has been recorded at their fair value $0.001 per share to MDwerks’ stockholders, which at closingas its fair value can be separated from the convertible note and its conversion is independent of the Merger Agreement represented approximately 87.4% of the issued and outstanding shares of the Company’s common stock.  In connection with the Merger, the Company changed its corporate name to MDwerks, Inc.

underlying note value. The Company has four subsidiaries. Xeni Medical Systems, Inc. ("Xeni Systems") was incorporated underalso recorded the lawsresulting discount on debt related to the conversion feature and is amortizing the discount using the effective interest rate method over the life of the State of Delaware on July 21, 2004.  Through February 28, 2009, Xeni Systems provided a Web-based package of electronic claims solutions to the healthcare provider industry through Internet access to its ‘‘MDwerks’’ suite of proprietary products and services so that healthcare providers could improve daily insurance claims transaction processing, administration and management.  Xeni Medical Billing, Corp. ("Xeni Billing") was incorporated under the laws of the State of Delaware on March 2, 2005. Xeni Systems and Xeni Billing have both discontinued their operations since these businesses were no longer generating enough revenue to sustain the Company. Xeni Financial Services, Corp. ("Xeni Financial") was incorporated under the laws of the State of Florida on February 3, 2005 and offers lending solutions for digital pen leases as well as factoring and other financing.  Digital Pen Applications, Inc. (“DPA”) was incorporated under the laws of the State of Florida on May 30, 2007, originally formed as Patient Payment Solutions, Inc. and was renamed on March 2, 2009 to Xeni Patient Access Solutions, Inc. and subsequently renamed to DPA on June 1, 2009. DPA sells D-PAS digital pen technology directly to healthcare providers such as nursing homes and hospitals and other health care facilities as well as other industries such as warehousing, shipping and transportation.

debt instruments.

Going concern

The accompanying unaudited consolidatedConcern These financial statements have been prepared assuming that the Company will continue as a going concern. Theconcern, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. As reflected in the accompanying unaudited financial statements, the Company has suffered losseshad a net loss of $41,451 and an accumulated deficit of $489,167 as of and for the three months ended March 31, 2023. Although management believes that it will be able to successfully execute a Business Combination, which includes third party financing and the raising of capital to meet the Company’s future liquidity needs, there can be no assurances in this regard. These matters raise substantial doubt about itsthe Company’s ability to continue as a going concern. While

Recently Issued Accounting Pronouncements - From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company is attempting to attain revenue growth and profitability,as of the growth has not been significant enough to support the Company’s daily operations. Management may need to raise additional funds by way of a public or private offering and make strategic acquisitions. Whilespecified effective date. Unless otherwise discussed, the Company believes in the viability of its strategy to improve sales volume and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent on the Company’s ability to further implement its new business plan and generate revenue. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that the actions presently being taken to further implementeffect of recently issued standards that are not yet effective will not have a material effect on its business plan and generate revenue, including  institutional financing described in Notes 5, 7, and  8, provide the opportunity for the Company to continue as a going concern.

On April 20, 2009, we, along with our subsidiary Xeni Financial Services, Corp. (“XFS”), entered into a Loan and Securities Purchase Agreement (the “Loan Agreement”) with Vicis Capital Master Fund (“Vicis”), dated April 15, 2009 pursuant to which Vicis loaned the Company $3,851,375 (the “Vicis Note”) comprised of new funding of $3,200,000, a prior advance of $300,000, and accrued interest, and professional and other fees of $351,375 relative to prior loans and commitments.

As reflected in the accompanying unaudited consolidated financial statements, the Company has a stockholders’ deficiency of $11,012,528 and working capital of $107,189 at September 30, 2009.
Basis of presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Item 310(b) of Regulation S-K. Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2008 and notes thereto and other pertinent information contained in the Form 10-K of the Company for the year ended December 31, 2008 as filed with the Securities and Exchange Commission (the ‘‘Commission’’). Theposition or results of operations forupon adoption.

In August 2020, the nine months ended September 30, 2009 are not necessarily indicative of whatFASB issued Accounting Standards Update (“ASU”) 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40)(“ASU 2020-06”). ASU 2020-06 simplifies the results will beaccounting for the full fiscal year ending December 31, 2009.


6

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Consolidation policy
The accompanying unaudited consolidated financial statements include the accounts of MDwerks, Inc. and its subsidiaries.  All material intercompany balances and transactions have been eliminated in consolidation.

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.
Fair value of financial instruments
Included in various investment related line items in the financial statements are certain financial instruments carried at fair value.  Other financialwith characteristics of liabilities and equity, including convertible instruments are periodically measured at fair value, such as when impaired, or, for preferred stock when carried at the lower of cost or market.

and contracts on an entity’s own equity. The fair value of an assetASU is the amount at which that asset could be bought or sold in a current transaction between willing parties, that is, other than in a forced or liquidation sale.  The fair value of a liability is the amount at which that liability could be incurred or settled in a current transaction between willing parties, that is, other than in a forced or liquidation sale.

Fair values are based on quoted market prices when available.  When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality.  In instances where there is little or no market activity for the same or similar instruments, the Company estimates fair value using methods, models and assumptions that management believes market participants would use to determine a current transaction price.  These valuation techniques involve some level of management estimation and judgment which becomes significant with increasingly complex instruments or pricing models.  Where appropriate, adjustments are included to reflect the risk inherent in a particular methodology, model or input used.

The Company's financial assets and liabilities carried at fair value have been classified, for disclosure purposes, based on a hierarchy defined by SFAS No. 157, Fair Value Measurements.   The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset’s or a liability’s classification is based on the lowest level input that is significant to its measurement.  For example, a Level 3 fair value measurement may include inputs that are both observable (Levels 1 and 2) and unobservable (Level 3).   The levelspart of the fair value hierarchyFASB’s simplification initiative, which aims to reduce unnecessary complexity in US GAAP. The ASU’s amendments are as follows:

Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.

Level 2 –  Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument.  Such inputs include market interest rates and volatilities, spreads and yield curves.

Level 3 – Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement.  Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date.

7


MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Financial assets and liabilities measured at fair value on a recurring basis

The following table provides information at September 30, 2009 about the Company’s financial assets and liabilities measured at fair value on a recurring basis.

  Level 1  Level 2  Level 3  Total 
             
Assets at fair value:            
Notes receivable        1,808,717   1,808,717 
Leases receivable        249,766   249,766 
Available-for-sale securities  170,430         170,430 
Total assets at fair value $170,430  $  $2,058,483  $2,228,913 
                 
Liabilities at fair value:                
 Notes payable     5,445,372  5,445,372 
Total liabilities at fair value $  $  $5,445,372  $5,445,372 
Cash and cash equivalents
For purposes of the consolidated statements of cash flows, the Company considers all highly liquid instruments purchased with a maturity of three months or less and money market accounts to be cash equivalents.
At various times, the Company has deposits in excess of the Federal Deposit Insurance Corporation limit. At September 30, 2009, the Company was approximately $17,000 in excess of the $250,000 per company limit.  The Company has not experienced any losses on these accounts.

Advertising
The Company expenses advertising costs as incurred. Advertising costs charged to operations were $0 for the nine months ended September 30, 2009 and 2008.
Property and equipment
Property and equipment are stated at cost. Depreciation and amortization are provided using the straight-line method over the estimated useful life.

8

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Revenue recognition
The Company follows the guidance of the Securities and Exchange Commission’s (‘‘SEC’’) Staff Accounting Bulletin (“SAB”) 104 for revenue recognition. In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectibility is reasonably assured. The following policies reflect specific criteria for the various revenue streams of the Company.
Revenue derived from term loans or lease purchases to unaffiliated companies are generally recognized as revenue when earned.  Revenue from term loans and lease purchases can include interest, administrative fees and other charges.
Revenue derived from claims purchased from unaffiliated healthcare providers are generally recognized when the claims are paid and the funds are collected.

Income taxes
Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under SFAS 109, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in net income (loss) in the period that includes the enactment date.
Loss per common share
Basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive securities outstanding during each period. For the nine months ended September 30, 2009 and 2008, the Company had outstanding options to purchase an aggregate of 4,793,834 and 5,632,530 shares of common stock, respectively, warrants to purchase an aggregate of 60,402,421 and 57,566,346 shares of common stock, respectively, 20,000 and 40,000 shares of common stock, respectively, issuable upon conversion of Series A preferred stock, 13,333,334 and 13,333,334 shares of common stock, respectively, issuable upon conversion of Series B preferred stock, and 1,474,074 and 1,913,580 shares of common stock, respectively, issuable upon conversion of notes payable which could potentially dilute future earnings per share. Diluted loss per common share has not been presented for the three and nine months ended September 30, 2009 and 2008 since the impact of the stock options and warrants would be antidilutive.

9

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Concentration of Credit Risk
The Company had three customers that accounted for all of total notes receivable for the nine months ended September 30, 2009.  These customers accounted for 66%, 22%, and 12% of such notes, respectively.  The Company received revenue from four pen leases and other financings.

Stock-based compensation

The fair value of stock options granted to employees, directors and others, is estimated at the date of grant using the Black-Scholes option-pricing model, which takes into consideration the share price at the date of grant, the exercise price of the option, the expected life of the option, expected interest rates and the expected volatility. The value of stock options, as noted, is recognized as compensation expense on a straight-line basis, over the requisite service period of the entire award.  The fair value of shares of common stock granted to employees, directors and others is estimated at the date of grant using the share price at the date of the grant.

Through December 31, 2008, due to the lack of adequate history of its own stock volatility, the Company estimated its own expected stock volatility based on the historical stock volatility of three other comparable publicly held companies. During 2008, as the Company accumulated its own volatility history over longer periods of time, the Company’s assumptions about its stock price volatility were based on a rate that was derived by taking into consideration the volatility rates of the aforesaid comparable publicly held companies as well as its own historical volatility rates. Beginning in 2009, the Company will estimate its expected stock volatility based on its own historical stock volatility rates.

Valuation Assumptions for Stock Options

The fair value for each stock option granted to employees and directors during the year ended December 31, 2008, was estimated at the date of grant using the Black-Scholes option-pricing model, assuming no dividends using 2.66% for the calculated risk-free interest rate, 10 years contractual life and 117.43% volatility.  No stock options were granted during the three and nine months ended September 30, 2009.

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option.

The contractual life represents the period of time that options granted are outstanding.  Options and their terms including required service period, contractual terms or vesting conditions are granted based upon recommendations of management and Board approval and vest based upon time and continuous service with the Company.  At November 23, 2009, there are 15,000,000 common shares authorized for stock option and common stock grants to employees, directors and others and there are approximately 6,600,000 common shares available for future issuances.

Recent accounting pronouncements

In June 2009, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Codification (“ASC”) 105, FASB Accounting Standards Codification (“ASC 105”).  The statement confirmed that the FASB Accounting Standards Codification (the “Codification”) is the single official source of authoritative GAAP (other than guidance issued by the SEC), superseding existing FASB, American Institute of Certified Public Accountants, Emerging Issues Task Force, and related literature.  The Codification does not change GAAP.  Instead, it introduces a new structure that is organized in an easily accessible, user-friendly online research.

In May 2008, the FASB issued FSP Accounting Principles Board (“APB”) Opinion No. 14-1, “Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement).” The FSP clarifies the accounting for convertible debt instruments that may be settled in cash (including partial cash settlement) upon conversion. The FSP requires issuers to account separately for the liability and equity components of certain convertible debt instruments in a manner that reflects the issuer’s nonconvertible debt (unsecured debt) borrowing rate when interest cost is recognized. The FSP requires bifurcation of a component of the debt, classification of that component in equity and the accretion of the resulting discount on the debt to be recognized as part of interest expense in our consolidated statement of operations. The FSP requires retrospective application to the terms of instruments as they existed for all periods presented. The Company adopted this FSP as of January 1, 2009.

10


MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 Recent accounting pronouncements (continued)
In May 2008, the FASB issued Statement of Financial Accounting Standards ("SFAS") No. 162, The Hierarchy of Generally Accepted Accounting Principles. This standard is intended to improve financial reporting by identifying a consistent framework, or hierarchy, for selecting accounting principles to be used in preparing financial statements that are presented in conformity with generally accepted accounting principles in the United States for non-governmental entities. SFAS No. 162 is effective 60 days following approval by the U.S. Securities and Exchange Commission ("SEC") of the Public Company Accounting Oversight Board's amendments to AU Section 411, The Meaning of Present Fairly in Conformity with Generally Accepted Accounting Principles. SFAS No. 162 will have no effect on the Company’s financial position, results of operations or cash flows.

In June 2008, the FASB ratified EITF Issue No. 07-5, “Determining Whether an Instrument (or an Embedded Feature) Is Indexed to an Entity’s Own Stock” (EITF 07-5). EITF 07-5 provides that an entity should use a two step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions. It also clarifies on the impact of foreign currency denominated strike prices and market-based employee stock option valuation instruments on the evaluation. EITF 07-5 is effective for fiscal years beginning after December 15, 2008. We do not expect EITF 07-5 to have a material impact on the preparation of our consolidated financial statements.

In April 2009, the FASB issued FSP FAS 141(R)-1, Accounting for Assets Acquired2023, and Liabilities Assumed in a Business Combination That Arise from Contingencies (“FSP FAS 141(R)-1”). This pronouncement amends SFAS No. 141-R to clarify the initial and subsequent recognition, subsequent accounting, and disclosure of assets and liabilities arising from contingencies in a business combination. FSP SFAS No. 141(R)-1 requires that assets acquired and liabilities assumed in a business combination that arise from contingencies be recognized at fair value, as determined in accordance with SFAS No. 157, if the acquisition-date fair value can be reasonably estimated. If the acquisition-date fair value of an asset or liability cannot be reasonably estimated, the asset or liability would be measured at the amount that would be recognized in accordance with FASB Statement No. 5, “Accounting for Contingencies” (SFAS No. 5), and FASB Interpretation No. 14, “Reasonable Estimation of the Amount of a Loss.” FSP SFAS No. 141(R)-1 became effective for Companies as of January 1, 2009. As the provisions of FSP FAS 141(R)-1 are applied prospectively to business combinations with an acquisition date on or after the guidance became effective,interim periods within those fiscal years. The Company is currently evaluating the impact to the Company cannot be determined until the transactions occur. No such transactions occurred during 2009.
In April 2009, the FASB issued FSP FAS No. 107-1 and Accounting Principles Board (“APB”) 28-1, Interim Disclosures about Fair Value of Financial Instruments, which amends SFAS No. 107, Disclosures about Fair Value of Financial Instruments, (“SFAS No. 107”) and APB Opinion No. 28, “Interim Financial Reporting,” respectively, to require disclosures about fair value ofASU 2020-06 on its financial instruments in interim financial statements, in addition to the annual financial statements as already required by SFAS No. 107. FSP FAS 107-1 and APB 28-1 will be required for interim periods ending after June 15, 2009. As FSP FAS 107-1 and APB 28-1 provide only disclosure requirements, the application of this standard will not have a material impact on the Company’s results of operations, cash flows or financial position.

In May 2009, Statement of Financial Accounting Standards No. 165statements.

NOTE 3Subsequent Events was issued.  The objective of this Statement is to establish general standards of accounting for disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued.  In accordance with this Statement, an entity should apply the requirements to interim or annual financial periods ending after June 15, 2009.  Management intends to adopt this new standard with the filing of this Quarterly Report on Form 10-Q.  The adoption of this new standard is expected to impact disclosure and therefore is not expected to have a material impact on the financial statements of the Company.


The Company does not believe that any other recently issued, but not yet effective accounting standards will have a material effect on the Company’s consolidated financial position, results of operations or cash flows.

Reclassifications

For comparability, certain September 30, 2008 amounts have been reclassified, where appropriate, to conform to the financial statement presentation used at September 30, 2009.

11

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009
NOTE 2 — ACCOUNTS NOTES AND LEASES RECEIVABLE
Accounts receivable are recorded when revenue has been recognized but not yet collected. PAYABLE

The Company had net $459,761accounts payable balance of accounts receivable at September 30, 2009$17,175 as of March 31, 2023 and $188,048 at$34,478as of December 31, 2008.2022 and related to amounts owed for various professional services and public company related expenses.

9

At September 30, 2009, the

NOTE 4 - ADVANCES PAYABLE

The Company had advanced fundingadvances aggregating $104,204 as of December 31, 2022 and $94,873 as of March 31, 2023 from a non-related third party in order to three customers under lines of creditcover legal, accounting and note agreements aggregating $1,808,717. Advances under the lines of credit are due to be repaid under the specific payment terms of the agreements.  other various public company related operating expenses.

The Company charges the customers interest and other charges as defined in the agreements.   At December 31, 2008, the Company had advanced funding to two healthcare providers under lines of credit and note agreements aggregating $1,277,722.

The Company has four secured notes receivable in the aggregate amount of approximately $1,200,000 from one client that were all due and payable on September 30, 2009 and are now in default.  Interest due through October 31, 2009 of $91,811 was paid in full on November 18, 2009. The client has recently received partial financing from unaffiliated sources and anticipates further financing, some of which will be used to pay down a portion of the notes due to the Company. Such payments will depend upon the amount of financing raised collectively by the client and will comprise 15% of funding up to $500,000, 20% of funding from $500,000 to $1,000,000 and 25% of all amounts above $1,000,000. The due dates will then be extended every 30 days upon such payments and an extension fee will be accrued. Interest must be current at all times. The notes would be paid on this continuing 30 day partial basis from the percentages stated above and management believes that these notes will ultimately be paid in full.

In addition, there are two leases receivable purchased from the above client that are in payment default and as per the terms of the lease agreements, these leases are being repurchased by the client at the discounted fair market value of $175,000, which is 80% of the amount that would have been paid to us over the life of the leases. Such payment is to be made no later than December 21, 2009 or the price will revert to the mandatory $220,000.  Four other leases are current through September 30, 2009 and the October and November payments are to be made before November 30, 2009.
Accounts and notes receivable are reported at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off receivables against the allowance when a balance is determined to be uncollectible.  At September 30, 2009 and December 31, 2008, certain amounts were in excess of 90 days, therefore, the Company maintained a $200,000 allowance for doubtful accounts that was recorded at December 31, 2008 for receivables due from one customer.

NOTE 3 — AVAILABLE-FOR-SALE SECURITIES

On June 16, 2008, the Company restructured one healthcare provider’s notes receivable which were due and payable to the Company on June 15, 2008.  Notes receivable of $175,000 were paid off and the remaining balance was consolidated into a new promissory note totaling $395,835 with a new maturity date of September 30, 2009.  As consideration for the changes to the termsrepaid $9,331 of these notes, among other fees, the Company was given 920,000 shares of the healthcare provider’s common stock when the stock was valued at $0.69 per share, 1,000,000 shares when the stock was valued at $0.31 per share and 550,000 shares when the stock was valued at $0.20 per share as quoted on the OTC Bulletin Board.  These stock receipts were recorded as interest income of $1,054,800 at December 31, 2008.  At September 30, 2009, the stock price was $0.069 per share resulting in an $884,370 decrease in the value of the Available-for-sale securities.  The Company will revalue these securities on a quarterly basis.  These revaluations will correspondingly adjust the Accumulated other comprehensive income/loss reported in the Stockholders’ Deficiency section of the Balance Sheet.  The Company does not plan to sell these securities within the next twelve months and has recorded such securities as a long-term asset.
NOTE 4 — PROPERTY AND EQUIPMENT
Property and equipment consisted of the following:
   Estimated Life 
September 30,
2009
  
December 31,
2008
 
Office furniture and equipment 5-7 Years $30,174  $30,174 
Computer equipment and software 3-5 Years  181,190   197,157 
Total    211,364   227,331 
Less: accumulated depreciation    (185,728)  (179,211)
Property and equipment, net   $25,636  $48,120 
Depreciation expense for the nine months ending September 30, 2009 and 2008 was $22,484 and $30,770, respectively.   The Company lowered the estimated life for computer equipment to three years in December 2008.

12


MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 5 — NOTES PAYABLE
 On each of October 19, 2006 and November 9, 2006 we received gross proceeds of $2,500,000 for a total of $5,000,000 in connection with a financing provided by Gottbetter Capital Master, Ltd. (in liquidation) “Gottbetter”, an unaffiliated accredited institutional investor.  Pursuant to the terms of a Securities Purchase Agreement, we issued two senior secured convertible promissory notes to Gottbetter, each in the original principal amount of $2,500,000 at an initial conversion price of $2.25 per share (each a ‘‘Senior Note’’ and collectively, the ‘‘Senior Notes’’), five-year Series D Warrants to purchase 375,000 shares of our common stock at a price of $2.25 per share (‘‘Series D Warrants’’) and five-year Series E Warrants, as amended, to purchase 541,666 shares of our common stock at a price of $2.25 per share (‘‘Series E Warrants’’).
On November 14, 2008, the Company received $300,000 as part of a potential funding with Debt Opportunity Fund LLLP (“DOF”). This funding was not consummated and a portion of the funds escrowed were used in the April 20, 2009 transaction described below and this $300,000 loan was included in April 20, 2009 Note described below.
The Company valued the Notes Payable at their face value and calculated the beneficial conversion feature of the warrants using Black Scholes in deriving a discount that is being amortized over the term of the Notes as interest expense using a straight line method.

On November 6, 2008, the Company temporarily reduced the conversion price set forth in the Senior Note issued to Gottbetter on October 19, 2006 (the “October Note”) from $2.25 per share to $0.303 per share with respect to a one-time conversion of  $433,334 of Conversion Amount (as defined in the October Note).  After the conversion price was reduced, Gottbetter converted $433,334 of Conversion Amount into 1,430,143 shares of Common Stock of the Company.  The Company recorded a debt conversion expense of $371,265 for the difference between the original conversion price of $2.25 per share and the one-time conversion price of $0.303 per share.  In connection with the reduction in the conversion price of the October Note, both Gottbetter and Vicis waived all anti-dilution adjustments to which they would have been entitled under the terms of the securities that they hold as result of the reduction of the conversion price of the October Note.   The remaining principal balance of these Notes at September 30, 2009 and December 31, 2008 was $3,316,666 which is convertible to purchase shares of our common stock, at the original conversion price of $2.25 per share.
On November 6, 2008, pursuant to a Securities Purchase Agreement by and between Vicis and Gottbetter, Vicis  purchased from Gottbetter, for a purchase price of $2,250,000, all of Gottbetter's rights, title and interest in and to:
(i) that certain Securities Purchase Agreement, dated as of October 19, 2006, by and between the Company and Gottbetter pursuant to which the Company issued to Gottbetter: (A) the Senior Notes, (B) Series D Warrants to purchase an aggregate of 375,000 shares of Common Stock; and (C) Series E Warrants to purchase an aggregate of 541,667 shares of Common Stock of the Issuer (the “Series E Warrants”),
(ii) the Senior Notes;
(iii) Series D Warrants to purchase an aggregate of 875,000 shares of Common Stock at and exercise price of $0.75 per share;
(iv) Series E Warrants to purchase an aggregate of 541,667 shares of Common Stock at and exercise price of $0.75 per share;
(v) the Security Agreement, dated as of October 19, 2006, by and between the Company and Gottbetter;
(vi) the Guaranty Agreement, dated as of October 19, 2006, by and among the Company, MDwerks Global Holdings, Inc., Xeni Medical Systems, Inc., Xeni Financial Services, Corp., Xeni Medical Billing Corp. and Gottbetter; and
(vii) the Registration Rights Agreement, dated as of October 19, 2006, by and between the Company and Gottbetter.

13

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 5 — NOTES PAYABLE (continued)
On April 20, 2009, we, along with our subsidiary Xeni Financial Services, Corp. (“XFS”), entered into a Loan and Securities Purchase Agreement (the “Loan Agreement”) with Vicis Capital Master Fund (“Vicis”), dated April 15, 2009 pursuant to which Vicis loaned the Company $3,200,000, subject to a deduction for an original issue discount of 2%. The proceeds from the loan from Vicis are being used for our corporate operations.

The Loan Agreement amount of $3,851,375 (the “Vicis Note”) comprised of the current loan of $3,200,000, and prior advances including the $300,000 loaned to us by DOF on November 14, 2008, accrued interest, and professional and other fees of $351,375 relative to prior loans and commitments. The Vicis Note bears interest at the rate of 13% per annum and is payable monthly, in arrears on the first day of each month, commencing on October 15, 2009. Principal payments in the monthly amount of $40,000 commence on October 15, 2009 and, subject to events of default specified in the Loan Agreement, the entire amount of principal and accrued but unpaid interest due under the note becomes due and payable on October 15, 2011.

In connection with the Loan Agreement and the financing provided under the Loan Agreement, we, XFS and each of our other subsidiaries, and Vicis entered into security agreements, dated April 15, 2009, pursuant to which we, XFS and our other subsidiaries granted a security interest to Vicis in substantially all of our assets. Each of our subsidiaries (other than XFS) also entered into a guaranty agreement to guaranty all obligations under the Loan Agreement and documents entered into in connection with the Loan Agreement.

As partial consideration for the loan provided by Vicis on April 20, 2009, the Company adjusted the Series J Warrant held by Vicis to reflect a decrease in the exercise price to $0.35 per share and a reduction in the number of shares underlying the Series J Warrant to 493,142 (the “Series J Warrant”) and issued a ten-year Series K Warrant to purchase 2,550,000 shares of our common stock at a price of $.35 per share (the “Series K Warrant”).

In connection with the issuance of the Series K Warrant, we and Vicis entered into a registration rights agreement, dated April 15, 2009, pursuant to which, among other things, we granted “piggyback” registration rights to Vicis for the Series K Warrant.

In addition, we also entered into an agreement with Vicis pursuant to which Vicis agreed to defer the principal and interest installment amounts with respect to the loans in the original aggregate principal amount of $5,000,000 ($3,316,666 at September 30, 2009) issued by us in favor of Vicis as assignee of Gottbetter Capital Master Fund Ltd. Vicis agreed to defer the payment of each installment amount commencing with the installment due April 1, 2009 and ending with the installment amount due April 1, 2010.  On April 1, 2010, in addition to the regular installment amount due on April 1, 2010, we are required to pay all deferred amounts in full, in one lump sum.

The promissory notes are as follows:
  
September 30,
2009
  
December 31,
2008
 
Notes payable $9,151,375  $5,300,000 
Less principal repayments  (1,550,000)  (1,250,000)
Less issuance of common stock in connection with debt conversion  (433,334)  (433,334)
Notes payable outstanding   7,168,041   3,616,666 
Less: unamortized discount on notes payable   (1,722,669)   (2,325,796)
Notes payable, net   5,445,372   1,290,870 
Less current portion   (498,512)   (1,290,870)
Notes payable, net of discount of $1,722,669 at September 30, 2009 and $2,325,796 at December 31, 2008, less current portion $4,946,860  $ 
For the nine months ended September 30, 2009 and September 30, 2008, amortization of the debt discount amounted to $747,784 and $930,627, respectively.  Forduring the three months ended September 30, 2009 and September 30, 2008 amortization of the debt discount amounted to $177,538 and $890,734) respectively.

14

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009
NOTE 6 — DIVIDENDS PAYABLE 

Each share of Series B Preferred Stock (as further described in Note 7) is entitled to cumulative dividends at the annual rate of 8% of the stated value of the Series B Preferred Stock for the September 28, 2007 and January 18, 2008 financings and 12% of the stated value of the Series B Preferred Stock for the March 31, 2008 financing.2023. The stated value of each share of Series B Preferred Stock is $10,000.  Dividendsadvances are payable in cash or additional shares of Series B Preferred Stock.  Dividends of $1,738,132unsecured, non-interest bearing and $948,222 have been accrued at September 30, 2009 and December 31, 2008, respectively, but are not payable until there are profits, surplus or other funds available for the payment of such dividends.

Each share of Series B Preferred Stock is convertible, at any time, at the option of the holder, into the number of shares of due on demand.

NOTE 5 – CAPITAL STOCK

Common Stock determined by dividing the stated value of the Series B Preferred Stock by the conversion price.  The initial conversion price of the Series B Preferred Stock is $0.75 per share.


NOTE 7 — TEMPORARY EQUITY

On September 28, 2007 we received gross proceeds of $2,000,000 (net proceeds of $1,691,445 after repayment of a $250,000 31-day August 31, 2007 Convertible Note, interest and closing expenses) from Vicis.  In connection with the financing, pursuant to the terms of a Securities Purchase Agreement, we issued 200 shares of Series B Convertible Preferred Stock (a “Series B Preferred Stock”), a seven year Series F Warrant to purchase 1,500,000 shares of our common stock at a price of $2.25 per share and a seven year Series G Warrant to purchase 1,000,000 shares of our common stock at a price of $2.50 per share.  As security for our obligations, we, along with our subsidiaries entered into Security Agreements with the Investor, pursuant to which we granted a security interest in all of our assets, except for the accounts receivable and certain contract rights of Xeni Financial, to Vicis. The fair market value of each stock warrant was estimated on the date of grant using the Black-Scholes option-pricing model in accordance with SFAS No. 123R using the following weighted-average assumptions: expected dividend yield 0%; risk-free interest rate of 4.23%; volatility of 116% and an expected term of 7 years.

On December 3, 2007 we received gross proceeds of $575,000 from Vicis and in connection with the financing, we issued a Convertible Note to Vicis which bore interest at the rate of 8% per year.  Subject to certain prepayment provisions, unpaid principal and interest due under the Convertible Note was due and payable on December 2, 2008.  On March 31, 2008, both interest and principal on this Note were paid in full as part of the March Securities Purchase Agreement described below.

On January 18, 2008, we received net proceeds of $500,000 from Vicis.  In connection with the financing, we and Vicis entered into a Securities Purchase Agreement, dated January 18, 2008 (the “January Securities Purchase Agreement”), pursuant to which we issued 50 shares of Series B Preferred Stock, a seven year Series F Warrant to purchase 375,000 shares of our common stock at a price of $2.25 per share and a seven year Series G Warrant to purchase 250,000 shares of our common stock at a price of $2.50 per share. The fair market value of each stock warrant was estimated on the date of grant using the Black-Scholes option-pricing model using the following weighted-average assumptions: expected dividend yield 0%; risk-free interest rate of 4.75%; volatility of 118% and an expected term of 7 years.

On March 31, 2008, we received net proceeds of $6,809,794 from Vicis.  In connection with this $7,500,000 Note Payable to Vicis, we and Vicis entered into a Securities Purchase Agreement, dated March 31, 2008 (the “March Securities Purchase Agreement”), pursuant to which we issued 750 shares of Series B Convertible Preferred Stock, par value $0.001 ( “Series B Preferred Stock”), a ten year Series H Warrant to purchase 53,333,334 shares of our common stock at a price of $0.75 per share (the “Series H Warrant”), and pursuant to which Vicis surrendered for cancellation all Series F Warrants and all Series G Warrants held by Vicis, which warrants were exercisable in the aggregate for 3,125,000 shares of our common stock. The fair market value of each stock warrant was estimated on the date of grant using the Black-Scholes option-pricing model using the following weighted-average assumptions: expected dividend yield 0%; risk-free interest rate of 2.46%; volatility of 117% and an expected term of 7 years.

15

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 7 — TEMPORARY EQUITY (continued)

The conversion price is subject to adjustment for stock splits, dividends, subdivisions, distributions, reorganizations and similar transactions.  Furthermore, the conversion price is also subject to adjustment in the event of the issuance of securities for a price below the conversion price then in effect or the issuance of convertible securities with an exercise or conversion price that is less than the then current conversion price for the shares of Series B Preferred Stock.

Since the redeemable preferred stock contains substantive conversion rights that remain with the holder until maturity, this preferred stock is required to be recorded as “temporary equity”.

To the extent that any shares of Series B Preferred Stock remain outstanding on March 31, 2010, each holder thereof shall have the option to either require us to redeem such holder’s shares of Series B Preferred Stock or convert such holder’s shares of Series B Preferred Stock into shares of Common Stock at the conversion price then in effect.  Since the redemption is contingent upon the holder’s not exercising their option to convert into a fixed number of shares, the Series B Preferred Stock is classified as temporary equity.

At September 30, 2009 and December 31, 2008, there were 1,000 shares of Series B Preferred Stock issued and outstanding.


The mandatorily redeemable convertible Series B preferred stock has been recorded as follows:

  
September 30,
2009
  
December 31,
2008
 
Mandatorily redeemable convertible Series B preferred stock $10,000,000  $10,000,000 
Less: unamortized discount on preferred stock  (2,379,165)  (5,947,917)
Mandatorily redeemable convertible Series B preferred stock, net $7,620,835  $4,052,083 
16

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 8 — STOCKHOLDERS’ EQUITY
Common stock  

The Company is authorized to issue 200,000,000 300,000,000shares of Commoncommon stock, $.001$0.001 par value, with such designations, rights and preferences as may be determined from time to time by the Boardvalue. At March 31, 2023, there were 123,401,506 shares of Directors. At September 30, 2009, there are 17,990,208 sharescommon stock issued and outstanding.


During the three month period ended March 31, 2023, 1,141,298 shares were sold and issued for $85,598

Preferred stock

Stock

The Company is authorized to issue 10,000,000 shares of preferred stock, $.001$0.001 par value, with such designations, rights and preferences as may be determined from time to time by the Board of Directors, of which 1,00010,000,000 shares are designated Series A Convertible Preferred stock and 1,500 shares are designated Series B Convertible Preferred stock.

The Company is authorized to issue 1,000 shares of Series A Convertible Preferred stock, $0.001 par value with such designations, rights and preferences as set forth in the Certificate of Designations Designating Series A Convertible Preferred stock. Between February 1, 2006 and September 30, 2006, the Company sold 28.3 Units to accredited investors. Stock.

Each unit consists of one share of our Series A Convertible Preferred Stock, par value $.001 per share, and a detachable, transferable Series A Warrant to purchase 20,000 shares of our common stock, at a purchase price of $3.00 per share. Between August 11, 2006 and September 30, 2009, 27.3 shares of Series A Convertible Preferred Stock were convertedis convertible into 546,667100 shares of common stock, leavingand each share of Series A Preferred Stock has the same number of common share votes prior to conversion as it would if fully converted to be used in voting on any company matter requiring a vote of shareholders. At March 31, 2023, there were 8,957,500shares issued and outstanding.

NOTE 6 – CONTINGENCY

In the ordinary course of business, the Company may become a party to lawsuits involving various matters. The impact and outcome of litigation, if any, is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company believes the ultimate resolution of any such current proceeding will not have a material adverse effect on our continued financial position, results of operations or cash flows.

NOTE 7 – SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet and up to June 8, 2023, the date that the financial statements were issued. In the subsequent period, the Company issued 1,333,333 shares for $100,000. Management has determined that there are no other items requiring disclosure or adjustment.

10

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Overview

Plan of Operations

As of March 31, 2023, we had not commenced any operations. Our activities relate to our focus on effecting a “reverse merger,” capital exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one (1)or more unrelated businesses (a “Business Combination”) that would benefit from our public reporting status. We also completed a change of control transaction on July 21, 2022 (the “Change of Control”). See “—Recent Developments—Change of Control”. In addition, in furtherance of our plans to consummate a Business Combination, on January 19, 2023, we entered into an Exchange Agreement to acquire RF Specialties LLC (“RFS”) and on February 13, 2023, we entered into a Merger Agreement to acquire Two Trees Beverage Co. (“Two Trees”). See “—Recent Developments—Planned Acquisitions”.

Recent Developments

Change of Control

On July 21, 2022, in connection with the change of control and composition of the Board of Directors of the Company (the “Board”), the Company entered into a Stock Purchase Agreement (the “SPA”) with (i) Tradition Reserve I LLC (“Buyer”); and (ii) Ronin Equity Partners, Inc. (“Seller”).

Pursuant to the SPA, on July 21, 2022 (the “Closing Date”), the Seller sold to the Buyer 10,000,000 shares of the Company’s Series A Convertible Preferred Stock held by the Seller (the “Shares”), representing 100% of the Company’s authorized and issued preferred stock, as of the Closing Date. In exchange for the sale of the Shares to the Buyer, the Buyer paid the Seller a total purchase price of $520,000 (the “Purchase Price”).

Further, at the closing of the transactions contemplated by the SPA (which include, but are not limited to, the purchases and sales of the Shares described above) (the “Closing”), the parties agreed that as of the Closing:

a) The Forgiven Debt (as defined hereinafter) was forgiven, as well as the Asia Note (as defined hereinafter), and any other loan agreements between the Company and Asia Pacific Partners, Inc. (“APP”). The parties acknowledged and agreed that the Company was indebted to APP, an affiliate of the Seller, in the amount of approximately $239,444, comprised of (i) the principal amount and accrued interest pursuant to a convertible promissory note dated July 18, 2014 in the amount of $210,000 as originally issued by the Company to Azure Associates, Inc. and purchased by APP on July 28, 2020 (the “Asia Note”), and (ii) various cash advances for a total of $29,444 as advanced by APP to the Company for working capital (the “Asia Cash Advances” and, together with any and all amounts that may have been due and payable pursuant to the Asia Note, the “Forgiven Debt”);

b) The Company’s Board of Directors was required to undertake such actions as required to:

(i) Expand the Company Board to be a number of persons as determined by Buyer, and to name such persons as selected by Buyer as directors on the Company Board;

(ii) Name such persons as selected by Buyer as officers of the Company, to the positions as determined by Buyer; and

(iii) Following (i) and (ii), all of the directors and officers of the Company, other than those named in or pursuant to (i) and (ii) shall resign from all such positions with the Company.

The Closing was subject to certain customary closing conditions, including, but not limited to, the accuracy of the representations and warranties made by the parties, all necessary consents having been obtained to effect the transactions, and the receipt of any necessary government approvals in order to effect the transactions contemplated in the SPA.

Prior to the Closing of the SPA, voting control of the Company was held by the Seller, of which Jacob D. Cohen was the primary shareholder, and held voting and dispositive control over the Shares.

On the Closing Date, Buyer purchased the Shares, which both pre- and post-conversion represented approximately 98.23% of the Company’s outstanding at September 30, 2009.


The Company is authorized to issue 1,500voting securities, resulting in a change in control of the Company. Each share of preferred stock was convertible into 100 shares of Series B Convertible Preferredcommon stock, $0.001 par value with such designations, rights and preferenceseach share of preferred stock had the same number of common share votes prior to conversion as it would if fully converted to be used in voting on any company matter requiring a vote of shareholders. At the Closing Date, there were 18,010,208 shares of common stock issued and outstanding. Kerry Cassidy is the majority membership unit holder and Managing Member of the Buyer, and therefore is deemed to have voting and dispositive power over the Company’s Shares held by the Buyer.

As a result of the Closing, the Company was no longer a company controlled by the Seller. Prior to the Closing, the Company was a shell company, and following the Closing, the Company continues to be a shell company. There has been no change in the Company’s shell company status or the Company’s operations as a result of the Closing.

11

Planned Acquisitions

RF Specialties, Inc.

On January 19, 2023, we entered into an Exchange Agreement (the “Exchange Agreement”) by and between the Company, RFS and Keith A. Mort as the sole member of RFS. Pursuant to the terms of the Exchange Agreement, the Company agreed to acquire from Mr. Mort, and Mr. Mort agreed to sell to the Company, 100% of the equity interests and membership interests of RFS, in exchange for the issuance by the Company to Mr. Mort of 7,500,000 shares of the Company’s common stock (the “Exchange”). Immediately following the Exchange, RFS will be a wholly owned subsidiary of the Company.

The shares received by Mr. Mort in the Exchange (the “Exchange Shares”) will be subject to a 24-month lock-up; provided, however, that (i) one-third of the Exchange Shares will be released from the lock-up restrictions on the 12-month anniversary of the closing of the Exchange, and (ii) one-third of the Exchange Shares will be released from the lock-up restrictions on the 18-month anniversary of the closing of the Exchange. The remaining one-third of the Exchange Shares will be released from the lock-up restrictions on the 24-month anniversary of the closing of the Exchange.

The parties have made customary representations, warranties and covenants in the Exchange Agreement. In addition to certain customary closing conditions, the obligations of the Company to consummate the closing of the Exchange are subject to the satisfaction (or waiver by the Company), at or before the closing date, of certain conditions, including that (i) RFS will have provided to the Company audited financial statements for RFS for each of the two most recently ended fiscal years and unaudited financial statements for any other required interim periods (the “Financial Statements Closing Condition”), and (ii) the Company will have completed its due diligence review and examination of RFS to its satisfaction in its sole discretion (the “Due Diligence Closing Condition”).

The Exchange Agreement may be terminated on or prior to the closing date of the Exchange:

(a) By the mutual written consent of all the parties to the Exchange Agreement.

(b) By the Company (i) if the closing conditions applicable to all parties and applicable to the Company as set forth in the CertificateExchange Agreement, including the Financial Statements Closing Condition and the Due Diligence Closing Condition, have not been satisfied or waived by the Company, which waiver the Company may give or withhold in its sole discretion, by May 31, 2023 (the “Termination Date”); provided, however, that the Company may not terminate the Exchange Agreement if the reason for the failure of Designations Designating Series B Convertible Preferred stock.  any such condition to occur was the breach of the terms of the Exchange Agreement by the Company; or (ii) if there has been a material violation, breach or inaccuracy of any representation, warranty, covenant or agreement of RFS or Mr. Mort as set forth in the Exchange Agreement;

(c) By RFS and Mr. Mort acting together (i) if the closing conditions applicable to all parties and applicable to RFS and Mr. Mort have not been satisfied or waived by RFS and Mr. Mort, which waiver RFS and Mr. Mort may give or withhold in their sole discretion, by the Termination Date; provided, however, that RFS and Mr. Mort may not terminate the Exchange Agreement if the reason for the failure of any such condition to occur was the breach of the terms of the Exchange Agreement by any of RFS or Mr. Mort; or (ii) if there has been a material violation, breach or inaccuracy of any representation, warranty, covenant or agreement of the Company as set forth in the Exchange Agreement;

(d) By any party to the Exchange Agreement, if a court of competent jurisdiction or other governmental authority shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by the Exchange Agreement and such order or action shall have become final and nonappealable; or

(e) By the Company, if the Company, in its sole discretion, at any time prior to the closing of the Exchange determines that its due diligence review of RFS is not satisfactory to the Company.

Two Trees

On September 28, 2007, 200February 13, 2023, we entered into a Merger Agreement (the “Merger Agreement”), by and between the Company, MD-TT Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”), and Two Trees Beverage Co. (“Two Trees”).

12

The Merger Agreement provides that, subject to the terms and conditions set forth in the Merger Agreement, the parties wish to effect a business combination through a merger of Merger Sub with and into Two Trees (the “Merger”), subject to the terms and conditions set forth in the Merger Agreement, with Two Trees continuing as the surviving corporation (“Surviving Corporation”). As a result of the Merger, the certificate of incorporation of Two Trees as in effect immediately prior to the closing date will be the certificate of incorporation of the Surviving Corporation, and the bylaws of Two Trees as in effect immediately prior to the closing date will be the bylaws of the Surviving Corporation.

Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the Company’s Board of Directors will be expanded and a number of persons as named by Two Trees will be named to the Company Board such that such persons comprise a majority of the Company’s Board, and the Company’s Board as such newly constituted will name or replace any officers of the Company as it may determine. In addition, at the closing of the Merger, the directors and officers of Two Trees as in place immediately prior to the closing will remain in place as the directors and officers of the Surviving Corporation.

The board of directors of Merger Sub and the Company’s Board unanimously approved the transactions contemplated by the Merger Agreement, including the Merger, and the Company as the sole stockholder of Merger Sub approved the Merger Agreement and the Merger.

In consideration of the Merger Agreement, at the effective time of the Merger, each of the holders of Two Trees stock, subject to certain exceptions set forth in the Merger Agreement, shall have the right to convert all of the shares of Series B convertible preferredTwo Trees stock were issued with the September Securities Purchase Agreement.  On January 18, 2008, 50into a total of 60,000,000 shares of Series B convertible preferredCompany common stock, were issued withwhich shall be apportioned between the January Securities Purchase Agreement.  On March 31, 2008, 750Two Trees stockholders, pro rata, based on the number of shares of Series B convertible preferredTwo Trees stock shares were issued withheld by each of the March Securities Purchase Agreement.  At September 30, 2009 and December 31, 2008, there were 1,000Two Trees stockholders as of the closing of the Merger (the “Merger Consideration”).

Under the Merger Agreement, at the effective time of the Merger, each of the issued and outstanding shares of Series B convertible preferredcommon stock (See Note 7).

Common stock options
A summaryof Two Trees, subject to certain exceptions set forth in the Merger Agreement, shall be converted into shares of the statusCompany’s common stock.

At the effective time of the Company'sMerger, shares of Two Trees’ common stock generally will be treated in the following manner:

● (1) Any shares of Two Trees common stock held as treasury stock or held or owned by Two Trees or Merger Sub immediately prior to the effective time of the Merger will be canceled and retired and will cease to exist, and no consideration will be delivered in exchange therefor; and (2) each share of Two Trees common stock outstanding immediately prior to the effective time of the Merger, excluding shares to be canceled pursuant to (1) herein and excluding shares of Two Trees common stock options at September 30, 2009who have exercised and changes duringperfected appraisal rights for such shares in accordance with the period ending on that date is as follows:

  Shares  
Weighted
Average
Exercise Price
  
Aggregate
Intrinsic Value
 
Outstanding at December 31, 2008  5,405,080  $1.82  $ 
Granted         
Exercised         
Forfeited  (611,246)  2.44    
Outstanding at September 30, 2009  4,793,834  $1.74  $ 
Options exercisable at end of period  4,732,168  $1.75  $ 
Weighted-average fair value of options granted during the period           
17


MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009
NOTE 8 — STOCKHOLDERS’ EQUITY (continued)
CommonDelaware General Corporation Law, will be automatically converted solely into the right to receive a number of shares of Company common stock options (continued)
Inequal to those set forth in the Merger Consideration.

● No fractional shares of Company common stock will be issued in connection with previously granted stock optionsthe Merger and any fractional share otherwise issuable to any Two Trees stockholder will be rounded up to the issuancenext whole share.

● Each share of common stock of Merger Sub issued and outstanding immediately prior to certain employees, consultantsthe effective time of the Merger will be converted into and directors in May 2009,exchanged for one validly issued, fully paid and nonassessable share of common stock, $0.001 par value per share, of the Surviving Corporation. Each stock certificate of Merger Sub evidencing ownership of any such shares will, as of the effective time of the Merger, evidence shares of common stock of the Surviving Corporation.

According to the terms of the Merger Agreement, the Company recognized stock-based compensation expensecommon stock issued at the closing of $329,357the Merger will be subject to a lock-up, pursuant to which the Two Trees stockholders receiving shares of the Company’s common stock will not transfer or dispose of the shares except according to the following schedule: (1) one-third of the shares will be released from the restriction on the nine-month anniversary of the effective date of the Merger; (2) one-third of the shares will be released from the restrictions on the 18-month anniversary of the effective date of the Merger; and (3) the remaining one-third of the shares will be released from the restrictions on the 36-month anniversary of the effective date of the Merger.

At the effective time of the Merger, Two Trees’ stock options (the “Two Trees Options”) generally will be treated in the following manner:

● Two Trees option holders will exchange all of their Two Trees Options for options to acquire shares of Company common stock (the “MDwerks Options”).

● The MDwerks Options will provide for substantially the same terms as the Two Trees Options, other than (1) they will be fully vested at issuance, and will increase the number of shares of Company common stock underlying the MDwerks Options from the number of shares of Two Trees common stock underlying the Two Trees Options, and (2) will retain the same exercise price per share of Company common stock underlying the MDwerks Options as the exercise price per share of Two Trees common stock underlying the Two Trees Options, in each case as necessary to provide for the ninesame spread value for each applicable option holder.

13

Consummation of the Merger is subject to the satisfaction or waiver of customary closing conditions, including: (1) approval of the Merger Agreement by the Two Trees stockholders; (2) the absence of any law or order by a governmental authority of the United States or certain non-United States jurisdictions that has the effect of rendering illegal or prohibiting consummation of the Merger, or causing the Merger to be rescinded following the completion thereof. In addition, consummation of the Merger by the Company and Merger Sub are subject to the satisfaction or waiver of customary closing conditions, including that (i) the Company will have completed its due diligence review of Two Trees to its satisfaction in its sole discretion; and (ii) Two Trees will have provided to the Company audited financial statements for Two Trees and related auditor reports thereon, as provided in the Merger Agreement.

Pursuant to the terms of the Merger Agreement, Two Trees agreed that at the closing of the Merger, Joe Ragazzo, Two Trees’ Chief Executive Officer, will shall enter into an indemnification agreement, pursuant to which Mr. Ragazzo will agree to indemnify the Company for certain breaches of the representations and warranties of Two Trees.

The Merger Agreement contains customary representations, warranties and covenants made by each of the Company, Merger Sub and Two Trees, including, among others, covenants by Two Trees regarding the conduct of its business prior to the closing of the Merger.

Either the Company or Two Trees may terminate the Merger Agreement prior to the closing date if, among certain other circumstances, certain conditions of the closing have not been satisfied. The Merger Agreement may be terminated by the Company if, among other things, (1) the Two Trees stockholders vote against the adoption of the Merger Agreement; (2) any Action is brought by a third-party non-Affiliate to enjoin or otherwise restrict the consummation of the closing; or (3) within five business days after receipt by the opposing party of written notice thereof that the other party is not reasonably capable of curing a material breach of the Merger Agreement prior to the termination date thereof.

The parties intend, for U.S. federal income tax purposes, that the Merger will qualify as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended, and that the Merger Agreement was adopted as a plan of reorganization within the meaning of Treasury Regulations Section 1.368-2(g).

On February 16, 2023, the Company, Merger Sub and Two Trees entered into Amendment No. 1 to Merger Agreement (“Amendment No. 1”). Pursuant to the terms of Amendment No. 1, the Merger Agreement was amended to reflect Two Trees’ authorized, issued and outstanding capital stock as of the effective date of the Merger Agreement, which capital stock consisted of 15,000,000 shares of common stock, par value $0.0001 per share, of which 9,999,604.69 shares were issued and outstanding as of the effective date of the Merger Agreement, and 3,529,500 shares of preferred stock, par value $0.0001 per share, of which 2,045,672.16 shares were issued and outstanding as of the effective date of the Merger Agreement. In addition, pursuant to the terms of Amendment No. 1, the Merger Agreement was amended to replace Mr. Ragazzo with James Cassidy, Two Trees’ Chairman of the Board as the party to indemnify the Company for certain breaches of the representations and warranties of Two Trees.

Non-Reliance on Previously Issued Financial Statements

On May 15, 2023, M&K CPAS, PLLC, the Company’s independent registered public accounting firm (“M&K”), notified the Company that the Company’s balance sheet as of December 31, 2022, and the related statements of operations, statement of changes in stockholders’ equity (deficit), and cash flows (the “2022 Financial Statements”) included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on March 27, 2023 (the “10-K”) should be restated and should no longer be relied upon.

Subsequent to the Company’s filing of the 10-K, it was discovered that a bank account of the Company was not included in the 10-K, and the Company determined that the errors required adjustment of 2022 Financial Statements. This led to an understatement of certain expenses and an understatement of the Company’s cash balance.

The Company and M&K determined that the reporting effects of the above errors had a material impact to the 2022 Financial Statements included in the 10-K. As a result, the 2022 Financial Statements will be restated, and the Company will file an amendment to the 10-K with the SEC.

The Company’s management concluded that in light of the errors mentioned above, a material weakness existed in the Company’s internal control over financial reporting as of December 31, 2022, and the Company’s disclosure controls and procedures were not effective as of December 31, 2022.

Going Concern

Conditions exist that raise substantial doubt about our ability to continue as a going concern due to our recurring losses from operations, deficit in equity, and the need to raise additional capital to fund operations. The “going concern” opinion could impair our ability to finance our operations through the sale of debt or equity securities.

14

Results of Operations

Three Months Ended March 31, 2023 compared to Three Months Ended March 31, 2022

Revenues. We did not earn any revenues during the three months ended September 30, 2009March 31, 2023 and $2,197,482 for the nine months ended September 30, 2008.2022.

Operating Expenses. The Company recognized stock-based compensation expensereported operating expenses of $6,154$41,451, consisting primarily of legal, accounting and various other public company related expenses for the three months ended September 30, 2009 and $280,760March 31, 2023, compared to $5,494 for the three months ended September 30, 2008.

At September 30, 2009, the total future compensation expenseMarch 31, 2022. The $35,957 increase was primarily attributable to increased legal and accounting fees related to non-vested options not yet recognized inour public company reporting obligations, as well as our activities related to the consolidated statementtransactions involving the Change of operations is approximately $11,000, which will be recognized through September 2010.
Common stock warrants
A summary ofControl and the status of the Company's outstanding stock warrants granted as of September 30, 2009 and changes during the period is as follows:
  Shares  
Weighted
Average
Exercise Price
 
Outstanding at December 31, 2008  57,925,946  $0.80 
Granted  3,043,142   0.35 
Exercised      
Forfeited  (677,778)  2.50 
Outstanding at September 30, 2009  60,291,310  $0.74 
Common stock issuable upon exercise of warrants  60,291,310  $0.74 
NOTE 9 - RESTATEMENT

The Company has effected a restatement of its financial resultsplanned acquisitions discussed above.

Total Other Income. Total other income was $0 for the period ended September 30, 2008 (the “Restatement”). After reviewing certain accounting principles the Company had applied in previously issued financial statements, management determined that the Company’s accounting for Mandatorily Redeemable Convertible Series B Preferred Stock should have been recorded as Temporary Equity and not Debt and that previously issued Mandatorily Redeemable Convertible Series B Preferred Stock should not have been recorded as an extinguishment of debt when new Mandatorily Redeemable Convertible Series B Preferred Stock was issued on March 31, 2008. Consequently, management has restated its quarterly financial statements for the three and nine months ending September 30, 2008. For the three months ended September 30, 2008, these changes decreased net loss by $1,550,000 dueMarch 31, 2023, compared to a decrease in interest expense. For$0 for the ninethree months ended September 30, 2008, these changes decreased net loss by $3,994,204 due to a decrease in interest expense of $3,334,082 and due to the elimination of the loss on extinguishment of debt of $660,122. These changes also decreased current liabilities $2,500,000, increased temporary equity $2,638,192 and decreased stockholder’s deficiency $138,192. These changes in presentation of the Company’s Mandatorily Redeemable Convertible Series B Preferred Stock did not impact the cash balance at the end of the period.


18

MDWERKS, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2009

NOTE 10 — COMMITMENTS
Lease agreements
On February 1, 2008, the Company was assigned a master lease on its facility and a 5-year lease option was exercised which extends the master lease until July 2013.  Rent expense for the nine months ended September 30, 2009 and September 30, 2008 was $57,219 and $74,555, respectively.

Future minimum operating lease commitments at September 30, 2009 are as follows:

Year Ending
December 31
 Amount 
2009  16,216 
2010  52,891 
2011  52,805 
2012  55,446 
2013   33,267 
  $210,625 
19


Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Overview
During 2008, we shifted our focus from the electronic medical claims processing, funding and collection solutions and began focusing our efforts on purchasing and financing leases as well as directly selling digital medical equipment and services that provide a lower cost solution to physicians for converting medical records to a digital format as well as being able to create EMR with original intake forms.  The Company will also begin selling the digital medical equipment leases directly to the healthcare facilities as part of our licensing arrangement with the outside vendor that we are currently purchasing the leases from.  To date we have not sold any digital medical equipment; however since December 2008, we have financed six leases of such equipment and expect to derive approximately $410,000 in revenue from such financing activities over 36 to 48 month periods.  The digital pen and associated services can improve billing time and accuracy and allows for substantial savings on paper and record storage versus traditional EMR.

We also can provide term loans, factor receivables and finance medical equipment to improve our client’s cash flows.

Through March 31, 2009, all of our revenue was derived from our prior line of business,2022. There has been no change in other income.

Liquidity and Capital Resources

We believe that if we do not raise additional capital over the electronic medical claims processing, funding and collection solution business.  This partnext 12 months, we may be required to suspend or cease the implementation of our business wasplans.

As of March 31, 2023 and 2022, we had $41,228 and $0 cash, respectively. We anticipate that our current cash and cash equivalents and cash generated from financing activities will be insufficient to satisfy our liquidity requirements for the next 12 months. As of March 31, 2023, the Company had incurred operating losses since inception of $489,167. At March 31, 2023, the Company had a working capital deficit of $70,820.

The Company requires additional funding to meet its ongoing obligations and to fund anticipated operating losses. Management has expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on raising capital to fund its initial business plan and ultimately to attain profitable operations. These financial statements do not deemed viableinclude any longeradjustments relating to the recoverability and was closed downclassification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.

We expect to incur marketing, professional, and administrative expenses as well expenses associated with maintaining our filings with the Commission. We will require additional funds during this time and will seek to raise the necessary additional capital. If we are unable to obtain additional financing, we may be required to reduce the scope of our business development activities, which could harm our business plans, financial condition and operating results. Additional funding may not be available on February 27, 2009.


 Our present operations willfavorable terms, if at all. The Company intends to continue to be subjectfund its business by way of equity or debt financing and advances from related parties. Any inability to risks inherent in the establishing and acquiring of new businesses, including, among other things, efficiently deployingraise capital as needed would have a material adverse effect on our capital, developing our product and services offerings, developing and implementing our marketing campaigns and strategies and developing awareness and acceptance of our products. Our ability to generate future revenue will be dependent on a number of factors, many of which are beyond our control, including the pricing of other services, overall demand for our products, market competition and government regulation.

20


Critical Accounting Policies
The discussion and analysis of ourbusiness, financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
We apply the Securities and Exchange Commission's Staff Accounting Bulletin 104 for revenue recognition. In general, we record revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectibility is reasonably assured. We have identified the policy below as critical to our business operations and understanding of our financial results:
Through February 2009, the Company, through its subsidiaries, provided advance funding for medical claims and term loan services to unaffiliated healthcare providers that were customers of the Company. The customer advances were typically collateralized by Security Agreements granting first position liens on the medical claims submitted by its customers to third party payers (the ‘‘Payers’’). The advances were repaid through the remittance of payments of customer medical claims, by Payers, directly to the Company. The Company could withhold from these advances interest, an administrative fee and other charges as well as any amount for prior advances that remain unpaid after a specified number of days. These interest charges, administrative fees and other charges were recognized as revenue when earned. There was no right of cancellation or refund provisions in these arrangements and the Company had no further obligations once the services were rendered.

The Company, through its subsidiaries, also provided notes and claims purchasing for medical claims to unaffiliated healthcare providers that were customers of the Company. The customer advances were repaid through the remittance of payments of customer medical claims, by Payers.  The Company could charge interest, an administrative fee and other charges as well as any amount for prior advances that remain unpaid after a specified number of days. These interest charges, administrative fees and other charges were recognized as revenue when earned. Under certain circumstances, there were warranties and refund provisions in these arrangements and the agreements are non-cancellable without our consent.

Revenue derived from fees related to billing and collection services were generally recognized when the customer’s accounts receivable were collected.  Revenue from implementation fees were generally recognized over the term of the customer’s agreement. Revenue derived from maintenance, administrative and support fees were generally recognized at the time the services were provided to the customer.

The Company, through its subsidiaries, provides purchasing and financing of medical equipment and software leases from an unaffiliated healthcare customer. The customer assigns the rights to these leases and the Company is repaid directly from the monthly lease payments from the lessees.  The Company can receive interest, an administrative fee and other charges. These interest charges, administrative fees and other charges are recognized as revenue when earned. There is currently no right of cancellation or refund provisions in these arrangements and the Company currently has no further obligations once the services are rendered.  The underlying equipment contains a warranty from the manufacturer.

21


Results of Operations

 For the Nine Months Ended September 30, 2009 Versus the Nine Months Ended September 30, 2008
Revenue
For the nine months ended September 30, 2009, we recorded total revenue of $366,283.  Of this total, we recorded service fee revenue of $90,764, accounting for 24.8% of total revenue, and financing income of $275,519, accounting for 75.2% of total revenue.  For the nine months ended September 30, 2008, we recorded total revenue of $702,360. Of this total, we recorded service fee revenue of $420,212, accounting for 59.8% of total revenue, financing income of $195,464, accounting for 27.8% of total revenue, and claims purchase revenue of $86,684, accounting for 12.4% of total revenue.   The decrease in revenue from 2008 resulted primarily from the closing down of our advance funding and claims processing, billing and collecting business.
Operating Expenses
For the nine months ended September 30, 2009, total operating expenses were $2,983,021 as compared to $5,937,613 for the nine months ended September 30, 2008, a net decrease of $2,954,592 or 49.8%. Included in this net decrease for the nine months ended September 30, 2009 is the following:
operations.

1.We recorded compensation expense of $1,176,156 as compared to $4,144,549 for the nine months ended September 30, 2008. This $2,968,393 or 71.6% decrease was primarily attributable to amortization of stock options of $248,108 and executive bonuses of $106,250 during the nine months ended September 30, 2009 versus amortization of stock options of $2,197,482 and executive bonuses of $453,131 during the nine months ended September 30, 2008 and to lower salaries due to fewer employees needed for the digital pen business; and15

2.Consulting expense amounted to $533,084 as compared to $168,349 for the nine months ended September 30, 2008, an increase of $364,735, or 216.7%. This increase resulted from the addition of outside business development consultants; and
3.Professional fees amounted to $583,781 as compared to $492,901 for the nine months ended September 30, 2008, an increase of $90,880, or 18.4%. This increase was attributable to amortization of deferred offering costs and legal fees related to SEC filings and general corporate fund raising matters; and
4.Selling, general and administrative expenses were $690,000 as compared to $1,131,814 for the nine months ended September 30, 2008, a decrease of $441,814, or 39.0%. This decrease resulted from lower bad debt expense and lower employee benefits and payroll taxes due to lower salaries for the nine months ended September 30, 2009 as compared to the nine months ended September 30, 2008.
For the nine months ended September 30, 2009 and 2008, selling, general and administrative expenses consisted of the following:
  
September 30,
2009
  
September 30, 
2008
 
Employee benefits and payroll taxes $214,713  $337,994 
Information technology  47,712   169,352 
Occupancy and office expenses  110,356   167,534 
Other selling, general and administrative  317,219   456,934 
 Total selling, general, and administrative $690,000  $1,131,814 
Other Income (Expenses)
For the nine months ended September 30, 2009, interest and other income was $50,423 as compared to $1,084,420 for the nine months ended September 30, 2008, a decrease of $1,033,997. This decrease was principally due to the restructuring of notes receivable during the nine months ended September 30, 2008.
For the nine months ended September 30, 2009, interest expense was $1,302,573 as compared to $1,229,015 for the nine months ended September 30, 2008, an increase of $73,558. This increase was primarily due to higher notes payable.

22


Net Loss Before Deemed Preferred Stock Dividend

We reported a net loss of $3,868,888 for the nine months ended September 30, 2009 as compared to a net loss of $5,379,848 for the nine months ended September 30, 2008.

Deemed Preferred Stock Dividend

During the nine months ended September 30, 2009 and 2008, we recorded $4,318,662 and $3,286,414, respectively for a deemed preferred stock dividend arising from a beneficial conversion feature for warrants attached to Series B Convertible Preferred Stock issued and from dividends accrued on the Series B Convertible Preferred Stock.  Dividends are payable

Cash Flows

Cash Used in cash or additional shares of Series B Preferred Stock and are not payable until there are profits, surplus or other funds available for the payment of such dividends.


Net Loss Attributable to Common Shareholders

We reported a net loss attributable to common shareholders of $8,187,550, or $0.50 per common share for the nine months ended September 30, 2009 as compared to net loss attributable to common shareholders of $8,666,262, or $0.67 per common share for the nine months ended September 30, 2008.

For the Three Months Ended September 30, 2009 Versus the Three Months Ended September 30, 2008
Revenue
For the three months ended September 30, 2009, we recorded total revenue of $93,300. Of this total, we recorded service fee revenue of $7,840, accounting for 8.4% of total revenue, and financing income of $85,460, accounting for 91.6% of total revenue.  For the three months ended September 30, 2008, we recorded total revenue of $236,650. Of this total, we recorded service fee revenue of $109,762, accounting for 46.4% of total revenue, financing income of $63,901, accounting for 27.0% of total revenue, and claims purchase revenue of $62,987, accounting for 26.6% of total revenue.   The decrease in revenue from 2008 resulted primarily from the closing down of our advance funding and claims processing, billing and collecting business.

Operating Expenses

For the three months ended September 30, 2009, total operating expenses were $751,586 as compared to $1,369,923 for the three months ended September 30, 2008, a net decrease of $618,337 or 45.1%. Included in this net decrease for the three months ended September 30, 2009 is the following:
1.We recorded compensation expense of $211,807 as compared to $833,555 for the three months ended September 30, 2008. This $621,748 or 74.6% decrease was primarily attributable to amortization of stock options of $6,154 and executive bonuses of $13,750  during the three months ended September 30, 2009 versus amortization of stock option of $280,760 and executive bonuses of $58,750 during the three months ended September 30, 2008 and lower salaries due to fewer employees needed for the digital pen business; and
2.Consulting expense amounted to $153,596 as compared to $29,630 for the three months ended September 30, 2008, an increase of $123,966 or 418.4%. This increase resulted from the addition of outside business development consultants; and
3.Professional fees amounted to $232,185 as compared to $162,950 for the three months ended September 30, 2008, an increase of $69,235, or 42.5%. This expense was attributable to an increase in amortization of deferred offering costs and legal fees related to SEC filings and general corporate matters; and
4.Selling, general and administrative expenses were $153,998 as compared to $343,788 for the three months ended September 30, 2008, a decrease of $189,790, or 55.2%. This decrease resulted from lower bad debt expense, lower information technology expenses, and lower employee benefits and payroll taxes due to lower salaries for the three months ended September 30, 2009 as compared to the three months ended September 30, 2008.

23


For the three months ended September 30, 2009 and 2008, selling, general and administrative expenses consisted of the following:
  
September 30,
2009
  
September 30, 
2008
 
Employee benefits and payroll taxes  45,006   105,223 
Information technology  (18,619  84,568 
Occupancy and office expenses  30,568   53,959 
Other selling, general and administrative  97,043   100,038 
  $153,998  $343,788 
Other Income (Expenses)
For the three months ended September 30, 2009, interest and other income was $13,050 as compared to $425,901 for the three months ended September 30, 2008, a decrease of $412,851. This decrease was principally due to restructuring of notes receivable during the three months ended June 30, 2008.
For the three months ended September 30, 2009, interest expense was $392,634 as compared to $348,138 for the three months ended September 30, 2008, an increase of $44,496. This increase was primarily due to higher notes payable.

Net Loss Before Deemed Preferred Stock Dividend

We reported a net loss of $1,037,870 for the three months ended September 30, 2009 as compared to a net loss of $1,055,510 for the three months ended September 30, 2008.

Deemed Preferred Stock Dividend

During the three months ended September 30, 2009 and 2008, we recorded $1,339,494 and $1,489,584, respectively for a deemed preferred stock dividend arising from a beneficial conversion feature for warrants attached to Series B Convertible Preferred Stock issued and from dividends accrued on the Series B Convertible Preferred Stock.  Dividends are payable in cash or additional shares of Series B Preferred Stock and are not payable until there are profits, surplus or other funds available for the payment of such dividends.

Net Loss Attributable to Common Shareholders

We reported a net loss attributable to common shareholders of $2,377,364, or $0.13 per common share for the three months ended September 30, 2009 as compared to net loss attributable to common shareholders of $2,545,094, or $0.20 per common share for the three months ended September 30, 2008.

Liquidity and Capital Resources
Historically we used the proceeds from the sales of preferred stock through September 30, 2009 and proceeds from notes and loans payable for working capital purposes and to fund our gross notes, accounts and leases receivable of $2,718,244 owed to us at September 30, 2009. We will continue to advance funds under note agreements to providers that subscribe to our financial services lending solutions.

We believe we have sufficient funds and prospective business activity to conduct our business and operations as they are currently undertaken through the first quarter of 2010 during which time the Company will be pursuing additional financing.   We currently have no material commitments for capital expenditures.

24


Cash flows
At September 30, 2009, we had cash of $1,420,171.  On April 21, 2009, we received cash of approximately $3,100,000, in connection with a loan from Vicis.  The cash proceeds are being used for our corporate operations.
Activities. Net cash used in operating activities was $2,940,110 for the ninethree months ended September 30, 2009 as compared to $3,645,323 for the nine months ended September 30, 2008, a decrease of $705,213. This decrease is primarilyMarch 31, 2023 and 2022, were $58,754 and $1,000, respectively. The increase was attributable to a decreasean increase in the net loss, and the following:
1.Gottbetter and Vicis debt offering costs of $337,269 and debt discount costs of $747,784, as compared to debt related costs during the nine months ended September 30, 2008 of $1,115,451;
2.Stock-based compensation of $329,357 versus stock-based compensation expense of $2,197,482 for the nine months ended September 30, 2008;
3.A net increase in notes receivable, accounts receivable, leases receivable, and prepaid expenses aggregating $913,437 principally related to the increases in notes receivables, as compared to a net increase of  $1,632,343 for the nine months ended September 30, 2008;
4.A net increase in accounts payable and accrued expenses related topartially offset by an increase in operating activities aggregating $405,321, as compared to a decrease of $99,003 for the nine months ended September 30, 2008.
Net cash used in investing activities was $0, as compared to $2,018,434 for the nine months ended September 30, 2008.  For the nine months ended September 30, 2008, $2,000,000 was invested in certificates of deposit.

accounts payable.

Cash Provided by Financing Activities. Net cash provided by financing activities was $3,136,474 for the ninethree months ended September 30, 2009 as comparedMarch 31, 2023 and 2022 was $76,267 and $1,000, respectively. The increase was attributable to net cash provided by financing activities of $6,007,459 for the nine months ended September 30, 2008.  During the nine months ended  September 30, 2009, proceeds of $3,851,375 was received from a new Note,subscriptions agreements, offset by note repaymentsrepayment of a previous $300,000 note loaned to us by DOF and note placement and other note related costs totaling $414,901.  During the nine months ended September 30, 2008 proceeds of $8,000,000 was received from the sale of Series B Preferred Stock, offset by repayments of notes and loans payable totaling $1,795,671 and note placement and other note related costs totaling $196,870.

Off Balanceadvances payable.

Off-Balance Sheet Arrangements

We had

There are no off balanceoff-balance sheet arrangements at September 30, 2009.


25

currently contemplated by management or in place that are reasonably likely to have a current or future effect on the business, financial condition, changes in financial condition, revenue or expenses, result of operations, liquidity, capital expenditures and/or capital resources.

Recent Accounting Standards

The Company has implemented all new accounting standards that are in effect and that may impact its financial statements and does not believe that there are any other new accounting standards that have been issued that might have a material impact on its financial position or results of operations.

ITEM

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Not applicable

Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM

Item 4. CONTROLS AND PROCEDURES

(a)  Evaluation of Controls and Procedures.

Disclosure Controls and Procedures

The Company has established disclosure

Disclosure controls and procedures are controls and other procedures that are designed to ensure that material information relatingrequired to be disclosed in our reports filed or submitted under the Company,Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported, within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management including its consolidated subsidiaries, is made known on a timely basis to the officers who certify its financial reports and to other members of senior management and the Company’s board of directors. Based on their evaluation as of September 30, 2009, theour principal executive officer and principal financial officer ofas appropriate, to allow timely decisions regarding required disclosure.

The Company’s principal executive officer and principal financial officer have evaluated the Company have concluded thateffectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange ActAct) as of 1934) areMarch 31, 2023. Based upon such evaluation, the principal executive officer and principal financial officer have concluded that, as of March 31, 2023, the Company’s disclosure controls and procedures were not effective to ensure that the informationas required to be disclosed by the Company in the reports that it files or submitsunder Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

(b)  Act.

Changes in Internal Control overOver Financial Reporting

There were no changes toin our internal controlscontrol over financial reporting that occurred(as defined in Rule 13a-15(f) or 15d-15(f)) during the three monthsquarter ended September 30, 2009,March 31, 2023 that have materially affected, or are reasonably likely to materially impactaffect, our internal controls over financial reporting.


16
26



PART II — II—OTHER INFORMATION

Item 1 —1. Legal Proceedings

No material developmentsProceedings.

Currently we are not involved in ourany pending litigation previously reported.

or legal proceedings.

Item 2 —1A. Risk Factors.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Proceeds.

During the three months ended March 31, 2023, the Company sold 1,141,298 shares of common stock for aggregate proceeds of $85,598.

The above securities issuances were exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemptions provided by Regulation D and Section 4(a)(2), as applicable under the Securities Act.

Item 3 —3. Defaults Upon Senior SecuritiesSecurities.

None

Item 4. Mine Safety Disclosure.

None

Item 5. Other Information.

None

Item 6. Exhibits

Exhibit No.Description
2.1Merger Agreement, dated February 13, 2023, by and among MDwerks, Inc., MD-TT Merger Sub, Inc. and Two Trees Beverage Co. (incorporated by reference to Exhibit 2.1 to the registrant’s Current Report on Form 8-K filed with the SEC on February 17, 2023).
2.2Amendment No. 1 to Merger Agreement, dated February 16, 2023, by and among MDwerks, Inc., MD-TT Merger Sub, Inc. and Two Trees Beverage Co. (incorporated by reference to Exhibit 2.2 to the registrant’s Current Report on Form 8-K filed with the SEC on February 17, 2023).
2.3

Asset Purchase Agreement, dated as of May 31, 2023, by and between the registrant and Automotive Transmission Engineering Corp. (incorporated by reference to Exhibit 2.1 to the registrant’s Current Report on Form 8-K filed with the SEC on June 6, 2023).

10.1Exchange Agreement, dated as of January 19, 2023, by and among the registrant, RF Specialties LLC and Keith A. Mort (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the SEC on January 25, 2023).
31.1Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act*
31.2Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act*
32.1Certification of Principal Executive Officer and of Principal Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act**
101.INSInline XBRL Instance Document*
101.SCHInline XBRL Taxonomy Extension Schema Document*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document*
101.LABInline XBRL Taxonomy Extension Label Linkbase Document*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document*
104Cover Page Interactive Data File (embedded within the Inline XBRL document)*

*Filed herewith.
**Furnished herewith.

17

None.
Item 4 — Submissions of Matters

SIGNATURES

Pursuant to a Vote of Security Holders

Item 5 — Other Information
None.
Item 6 — Exhibits
31.1   Section 302 Certification of Principal Executive Officer
31.2   Section 302 Certification of Principal Financial Officer
32.1   Section 906 Certification of Principal Executive Officer
32.2   Section 906 Certification of Principal Financial Officer

27

SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 MDWERKS, Inc.
 MDWERKS, INC.
Date: June 8, 2023/s/ Steven C. Laker
 
November 23, 2009/s/ David M. BarnesSteven C. Laker
 
David M. Barnes, Chief Executive Officer
and Chief Financial Officer
 (Principal Executive Officer)principal executive officer, principal financial officer and principal accounting officer)

November 23, 2009/s/ Adam Friedman
Adam Friedman, Chief Financial Officer
(Principal Financial Officer)18

28